Another study reported that MTHFD1L was involved in colorectal cancer progression, and blocking MTHFD1L reduces the growth of colon cancer cells, thus providing an avenue to target this enzyme with small molecule inhibitors [14]. The gene discussed is MTHFD1L; the disease is malignant colon neoplasm.